USFDA grants nod for Amgen Uplizna as first treatment for rare immune disorder Ruchika Sharma4 April 2025 2:30 PM ISTThousand Oaks: Amgen has announced that the Company has received approval from the U.S. Food and Drug Administration (FDA) for...
Amgen Tarlatamab approved in UK for small cell lung cancer in adults Ruchika Sharma3 Jan 2025 12:57 PM ISTAmgen Limited has received approval for tarlatamab (Imdyllytra) from the Medicines and Healthcare products Regulatory Agency (MHRA) for the...
Amgen plans to open new technology, innovation site in Hyderabad Ruchika Sharma10 Aug 2024 3:45 PM ISTThousand Oaks: Amgen has announced plans to open a new technology and innovation site in Hyderabad, India. The site, known as Amgen India, will...
USFDA adds boxed warning for Amgen bone loss drug Prolia Ruchika Sharma22 Jan 2024 2:30 PM ISTNew Delhi: The U.S. Food and Drug Administration added a serious warning on the prescribing information for Amgen's drug Prolia to treat bone...
US FDA turns down full approval of Amgen lung cancer drug Lumakras Ruchika Sharma29 Dec 2023 4:30 PM ISTNew Delhi: The U.S. health regulator on Tuesday declined to grant traditional approval to Amgen's Lumakras for treating lung cancer patients with...
Amgen settles patent lawsuit over biosimilar of JnJ's Stelara Ruchika Sharma25 May 2023 2:50 PM ISTStelara is a biologic drug, meaning it is derived from living cells and cannot be exactly duplicated.
Patent infringement: Amgen sues Novartis to block generic osteoporosis, bone cancer drugs Ruchika Sharma3 May 2023 5:30 PM ISTAmgen said the proposed biosimilars infringe 21 patents covering Prolia and Xgeva.
Amgen wins patent appeal on psoriasis drug Otzela against Zydus Pharma (USA), Sandoz Ruchika Sharma22 April 2023 1:30 PM ISTThousand Oaks: Amgen has announced that the U.S. Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District...
AstraZeneca Tezspire approved for self administration in US with new pre filled pen Ruchika Sharma3 Feb 2023 12:15 PM ISTThe Tezspire pre-filled pen enables patients and caregivers to self-administer the medicine at home or in clinic via a simple process.
After Sanofi drops out of Horizon bid, Amgen emerges as frontrunner Ruchika Sharma12 Dec 2022 1:30 PM ISTSanofi said on Sunday that it was no longer in discussions with Horizon and does not intend to make an offer for it.
Amgen to acquire ChemoCentryx for USD 4 billion in cash Ruchika Sharma7 Aug 2022 2:15 PM ISTThousand Oaks: Amgen and ChemoCentryx, Inc., a biopharmaceutical company focused on orally administered therapeutics to treat autoimmune...
Expanded use of Amgen psoriasis drug Otezla gets USFDA okay Ruchika Sharma21 Dec 2021 11:00 AM ISTThousand Oaks: Amgen has recently announced that the U.S. Food and Drug Administration (FDA) has approved Otezla (apremilast) for the...
